Artery Research
Volume 3, Issue 4 , Pages 141-147 , December 2009

The role of “semicarbazide-sensitive amine oxidase” in the arterial wall

  • N. Mercier

      Affiliations

    • INSERM U961, Nancy, France
    • Henry Poincaré University, France
    • Corresponding Author InformationINSERM U961, Faculté de Médecine, 9 avenue de la Forêt de Haye, 54 500 Vandoeuvre-Les-Nancy, France.

References 

  1. Boomsma F, Derkx FH, van den Meiracker AH, Man in 't Veld AJ, Schalekamp MA. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci (Lond). 1995;88(6):675–679
  2. Garpenstrand H, Ekblom J, Backlund LB, Oreland L, Rosenqvist U. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in type 2 diabetes mellitus complicated by retinopathy. Diabet Med. 1999;16(6):514–521
  3. Meszaros Z, Szombathy T, Raimondi L, Karadi I, Romics L, Magyar K. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism. 1999;48(1):113–117
  4. Boomsma F, van Veldhuisen DJ, de Kam PJ, Man in't Veld AJ, Mosterd A, Lie KI, et al. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res. 1997;33(2):387–391
  5. Ishizaki F. Plasma benzylamine oxidase activity in cerebrovascular disease. Eur Neurol. 1990;30(2):104–107
  6. Boomsma F, Hut H, Bagghoe U, van der Houwen A, van den Meiracker A. Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation. Med Sci Monit. 2005;11(4):RA122–RA126
  7. Kurkijarvi R, Adams DH, Leino R, Mottonen T, Jalkanen S, Salmi M. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol. 1998;161(3):1549–1557
  8. Boomsma F, Bhaggoe UM, van der Houwen AM, van den Meiracker AH. Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology. Biochim Biophys Acta. 2003;1647(1–2):48–54
  9. Yu PH, Wright S, Fan EH, Lun ZR, Gubisne-Harberle D. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta. 2003;1647(1–2):193–199
  10. O'Sullivan J, O'Sullivan M, Tipton KF, Unzeta M, Del Mar Hernandez M, Davey GP. The inhibition of semicarbazide-sensitive amine oxidase by aminohexoses. Biochim Biophys Acta. 2003;1647(1–2):367–371
  11. Salmi M, Yegutkin GG, Lehvonen R, Koskinen K, Salminen T, Jalkanen S. A cell surface amine oxidase directly controls lymphocyte migration. Immunity. 2001;14(3):265–276
  12. Yegutkin GG, Salminen T, Koskinen K, Kurtis C, McPherson MJ, Jalkanen S, et al. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte–endothelium interactions under shear stress. Eur J Immunol. 2004;34(8):2276–2285
  13. Valente T, Sole M, Unzeta M. SSAO/VAP-1 protein expression during mouse embryonic development. Dev Dyn. 2008;237(9):2585–2593
  14. Abella A, Garcia-Vicente S, Viguerie N, Ros-Baro A, Camps M, Palacin M, et al. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia. 2004;47(3):429–438
  15. Garcia-Vicente S, Abella A, Viguerie N, Ros-Baro A, Camps M, Testar X, et al. The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha. J Physiol Biochem. 2005;61(2):395–401
  16. Salmi M, Stolen C, Jousilahti P, Yegutkin GG, Tapanainen P, Janatuinen T, et al. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. Am J Pathol. 2002;161(6):2255–2262
  17. Stolen CM, Madanat R, Marti L, Kari S, Yegutkin GG, Sariola H, et al. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications. FASEB J. 2004;18(6):702–704
  18. Gokturk C, Sugimoto H, Blomgren B, Roomans GM, Forsberg-Nilsson K, Oreland L, et al. Macrovascular changes in mice overexpressing human semicarbazide-sensitive amine oxidase in smooth muscle cells. Am J Hypertens. 2007;20(7):743–750
  19. Gubisne-Haberle D, Hill W, Kazachkov M, Richardson JS, Yu PH. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Ther. 2004;310(3):1125–1132
  20. Mathys KC, Ponnampalam SN, Padival S, Nagaraj RH. Semicarbazide-sensitive amine oxidase in aortic smooth muscle cells mediates synthesis of a methylglyoxal-AGE: implications for vascular complications in diabetes. Biochem Biophys Res Commun. 2002;297(4):863–869
  21. Yu PH, Lai CT, Zuo DM. Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem Res. 1997;22(5):615–620
  22. Cantini C, Kieffer P, Corman B, Liminana P, Atkinson J, Lartaud-Idjouadiene I. Aminoguanidine and aortic wall mechanics, structure, and composition in aged rats. Hypertension. 2001;38(4):943–948
  23. Corman B, Duriez M, Poitevin P, Heudes D, Bruneval P, Tedgui A, et al. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci U S A. 1998;95(3):1301–1306
  24. Koyama H, Yamamoto H, Nishizawa Y. RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases. Mol Med. 2007;13(11–12):625–635
  25. Yu PH, Zuo DM. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia. 1997;40(11):1243–1250
  26. Exner M, Hermann M, Hofbauer R, Kapiotis S, Quehenberger P, Speiser W, et al. Semicarbazide-sensitive amine oxidase catalyzes endothelial cell-mediated low density lipoprotein oxidation. Cardiovasc Res. 2001;50(3):583–588
  27. Jalkanen S, Salmi M. VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler Thromb Vasc Biol. 2008;28(1):18–26
  28. Hernandez M, Sole M, Boada M, Unzeta M. Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cells. Biochim Biophys Acta. 2006;1763(2):164–173
  29. Sole M, Hernandez-Guillamon M, Boada M, Unzeta M. p53 Phosphorylation is involved in vascular cell death induced by the catalytic activity of membrane-bound SSAO/VAP-1. Biochim Biophys Acta. 2008;1783(6):1085–1094
  30. Zorzano A, Abella A, Marti L, Carpene C, Palacin M, Testar X. Semicarbazide-sensitive amine oxidase activity exerts insulin-like effects on glucose metabolism and insulin-signaling pathways in adipose cells. Biochim Biophys Acta. 2003;1647(1–2):3–9
  31. Moldes M, Feve B, Pairault J. Molecular cloning of a major mRNA species in murine 3T3 adipocyte lineage. differentiation-dependent expression, regulation, and identification as semicarbazide-sensitive amine oxidase. J Biol Chem. 1999;274(14):9515–9523
  32. Mercier N, Moldes M, El Hadri K, Feve B. Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells. Biochem J. 2001;358(Pt 2):335–342
  33. Arvilommi AM, Salmi M, Jalkanen S. Organ-selective regulation of vascular adhesion protein-1 expression in man. Eur J Immunol. 1997;27(7):1794–1800
  34. Jaakkola K, Kaunismaki K, Tohka S, Yegutkin G, Vanttinen E, Havia T, et al. Human vascular adhesion protein-1 in smooth muscle cells. Am J Pathol. 1999;155(6):1953–1965
  35. Lyles GA, Singh I. Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta. J Pharm Pharmacol. 1985;37(9):637–643
  36. Lyles GA. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. Int J Biochem Cell Biol. 1996;28(3):259–274
  37. Lyles GA, Pino R. Properties and functions of tissue-bound semicarbazide-sensitive amine oxidases in isolated cell preparations and cell cultures. J Neural Transm Suppl. 1998;52:239–250
  38. El Hadri K, Moldes M, Mercier N, Andreani M, Pairault J, Feve B. Semicarbazide-sensitive amine oxidase in vascular smooth muscle cells: differentiation-dependent expression and role in glucose uptake. Arterioscler Thromb Vasc Biol. 2002;22(1):89–94
  39. Sibon I, Mercier N, Darret D, Lacolley P, Lamaziere JM. Association between semicarbazide-sensitive amine oxidase, a regulator of the glucose transporter, and elastic lamellae thinning during experimental cerebral aneurysm development: laboratory investigation. J Neurosurg. 2008;108(3):558–566
  40. Sibon I, Larrieu D, El Hadri K, Mercier N, Feve B, Lacolley P, et al. Semicarbazide-sensitive amine oxidase in annulo-aortic ectasia disease: relation to elastic lamellae-associated proteins. J Histochem Cytochem. 2004;52(11):1459–1466
  41. Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006;38(4):452–457
  42. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312(5770):117–121
  43. Smith-Mungo LI, Kagan HM. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 1998;16(7):387–398
  44. Maki JM, Rasanen J, Tikkanen H, Sormunen R, Makikallio K, Kivirikko KI, et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation. 2002;106(19):2503–2509
  45. Langford SD, Trent MB, Balakumaran A, Boor PJ. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase. Toxicol Appl Pharmacol. 1999;155(3):237–244
  46. Langford SD, Trent MB, Boor PJ. Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells. Cardiovasc Toxicol. 2002;2(2):141–150
  47. Mercier N, El Hadri K, Osborne-Pellegrin M, Nehme J, Perret C, Labat C, et al. Modifications of arterial phenotype in response to amine oxidase inhibition by semicarbazide. Hypertension. 2007;50(1):234–241
  48. Capdeville M, Coutard M, Osborne-Pellegrin MJ. Spontaneous rupture of the internal elastic lamina in the rat: the manifestation of a genetically determined factor which may be linked to vascular fragility. Blood Vessels. 1989;26(4):197–212
  49. Fornieri C, Baccarani-Contri M, Quaglino D, Pasquali-Ronchetti I. Lysyl oxidase activity and elastin/glycosaminoglycan interactions in growing chick and rat aortas. J Cell Biol. 1987;105(3):1463–1469
  50. Mercier N, Osborne-Pellegrin M, El Hadri K, Kakou A, Labat C, Loufrani L, et al. Carotid arterial stiffness, elastic fibre network and vasoreactivity in semicarbazide-sensitive amine-oxidase null mouse. Cardiovasc Res. 2006;72(2):349–357
  51. Vidrio H. Semicarbazide-sensitive amine oxidase: role in the vasculature and vasodilation after in situ inhibition. Auton Autacoid Pharmacol. 2003;23(5–6):275–283
  52. Vidrio H, Medina M. Hypotensive effect of hydroxylamine, an endogenous nitric oxide donor and SSAO inhibitor. J Neural Transm. 2007;114(6):863–865
  53. Vidrio H, Medina M, Gonzalez-Romo P, Lorenzana-Jimenez M, Diaz-Arista P, Baeza A. Semicarbazide-sensitive amine oxidase substrates potentiate hydralazine hypotension: possible role of hydrogen peroxide. J Pharmacol Exp Ther. 2003;307(2):497–504
  54. Conklin DJ, Cowley HR, Wiechmann RJ, Johnson GH, Trent MB, Boor PJ. Vasoactive effects of methylamine in isolated human blood vessels: role of semicarbazide-sensitive amine oxidase, formaldehyde, and hydrogen peroxide. Am J Physiol Heart Circ Physiol. 2004;286(2):H667–H676
  55. Mercier N, Kakou A, Challande P, Lacolley P, Osborne-Pellegrin M. Comparison of the effects of semicarbazide and beta-aminopropionitrile on the arterial extracellular matrix in the Brown Norway rat. Toxicol Appl Pharmacol. 2009;239(3):258–267
  56. Huang W, Alhenc Gelas F, Osborne-Pellegrin MJ. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat. Circ Res. 1998;82(8):879–890
  57. Gokturk C, Nilsson J, Nordquist J, Kristensson M, Svensson K, Soderberg C, et al. Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas. Am J Pathol. 2003;163(5):1921–1928
  58. Sole M, Hernandez M, Boada M, Unzeta M. Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line). J Neural Transm. 2007;114(6):763–767

PII: S1872-9312(09)00093-3

doi: 10.1016/j.artres.2009.10.002

Artery Research
Volume 3, Issue 4 , Pages 141-147 , December 2009

Article Tools

* Image Usage & Resolution